Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer

PURPOSE. Following the demonstrated efficacy and safety of eribulin mesylate in heavily pretreated patients with metastatic breast cancer, an exploratory analysis was performed to investigate the effect of age in these patients. METHODS. Data were pooled from two single-arm phase II studies and one...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O’Shaughnessy, Joyce
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Academia-Pharma Intersect
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983814/
https://ncbi.nlm.nih.gov/pubmed/24682463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0282
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados